PXDN and diabetic kidney disease: validated four diagnostic markers for DKD (tenascin C, peroxidasin, tissue inhibitor metalloproteinases 1, and tropomyosinin), using a human transcriptome GEO dataset and in a mouse model of DM and DKD [81].